Use of Erythropoietin Dosing and Associated Factors in Hemodialysis Patients
碩士 === 高雄醫學大學 === 醫務管理學研究所碩士在職專班 === 100 === Background: Taiwan frequently sat on the top list regarding to uremia prevalence in recent years. Uremic patients spent a lot of health care resources. Hemodialysis (HD) is the treatment used by the majority of uremic patients in Taiwan. Anemia is a commo...
Main Authors: | Chung Yu-Chieh, 鍾宇杰 |
---|---|
Other Authors: | Herng-Chia Chiu |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/70338032370843765947 |
Similar Items
-
Obesity may be erythropoietin dose-saving in hemodialysis patients
by: Ghada M. El-Kannishy, et al.
Published: (2018-06-01) -
Gender differences in dose of erythropoietin to maintain hemoglobin target in hemodialysis patients
by: J A Coronado Daza, et al.
Published: (2019-01-01) -
Erythropoietin Resistance in Hemodialysis Patients
by: Jacović Saša, et al.
Published: (2019-03-01) -
Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality
by: Elani Streja, et al.
Published: (2016-01-01) -
Antibodies to Erythropoietin Are Associated with Erythropoietin Resistance in Hemodialysis Patients in KwaZulu-Natal (South Africa)
by: Sherilene Benjamin, et al.
Published: (2020-01-01)